Last reviewed · How we verify
NCT05250414
Single-Sided Deafness in the Medicare Population
NA trial testing MED-EL Cochlear Implant System in Hearing Loss, Unilateral in 15 participants. Completed in 11 August 2025.
11 August 2025
Quick facts
| Lead sponsor | Med-El Corporation |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 27 June 2022 |
| Primary completion | 11 August 2025 |
| Estimated completion | 11 August 2025 |
| Sites | 3 locations across Canada, United States |
Drugs / interventions tested
- MED-EL Cochlear Implant System
Conditions studied
- Hearing Loss, Unilateral — all drugs for Hearing Loss, Unilateral →
Sponsor
Med-El Corporation — full company profile →
Who can join
65 and older, any sex, with Hearing Loss, Unilateral. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the safety and effectiveness of cochlear implantation in adults 65 years of age and older.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Improvements in Perceived Abilities and Speech Recognition in Quiet and Noise for Older Adults With Single-sided Deafness or Asymmetric Hearing Loss: A Multi-center Investigation.
Dillon MT, Smilsky K, Dunn CC, Sheets JJ, et al · · 2026 · cited 1× · PMID 41094701 · DOI 10.1097/mao.0000000000004667
Verify or expand the search:
- PubMed search for NCT05250414
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hearing Loss, Unilateral
Currently open trials in the same condition.
- NCT06058767 — Preschool Hearing Screening · NA · recruiting
- NCT05775367 — Cochlear Implants in Young Children With SSD · NA · recruiting
Other Med-El Corporation trials
Trials by the same sponsor.
- NCT07028619 — Benefits of Bimodal Streaming With MED-EL Cochlear Implants and Starkey Hearing Aids · NA · completed
- NCT06597747 — Design Improvements With SONNET 3 · NA · completed
- NCT03859648 — BONEBRIDGE Bone Conduction Implant in Adults · NA · terminated
- NCT03900897 — Expanded Indications in the MED-EL Pediatric Cochlear Implant Population · NA · completed
- NCT03236909 — Expanded Indications in the Adult Cochlear Implant Population · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05250414 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Med-El Corporation
- Last refreshed: 29 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05250414.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing